A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy-Reference-Cited by-同舟云学术

A phase II, single-arm, prospective study of bendamustine plus melphalan conditioning for second autologous stem cell transplantation in de novo multiple myeloma patients through a tandem transplant strategy

Published:2016-04-18 Issue:9 Volume:51 Page:1197-1203
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Martino M,Tripepi G,Messina G,Vincelli I D,Console G,Recchia A G,Gentile M,Molica S,Morabito F

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201694.pdf

Reference44 articles.

1. Röllig C, Knop S, Bornhäuser M . Multiple myeloma. Lancet 2015; 385: 2197–2208.

2. Ludwig H, Sonneveld P, Davies F, Bladé J, Boccadoro M, Cavo M et al. European perspective on multiple myeloma treatment strategies in 2014. Oncologist 2014; 19: 829–844.

3. Shah N, Callander N, Ganguly S, Gul Z, Hamadani M, Costa L et al. Hematopoietic stem cell transplantation for multiple myeloma: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2015; 21: 1155–1166.

4. Martino M, Morabito F . Autologous stem cell transplantation in multiple myeloma is not dead but alive and well. Expert Opin Biol Ther 2015; 15: 149–154.

5. van Rhee F, Giralt S, Barlogie B . The future of autologous stem cell transplantation in myeloma. Blood 2014; 124: 328–333.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing high dose melphalan;Blood Reviews;2023-12

2. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives;Critical Reviews in Oncology/Hematology;2023-07

3. Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation;Annals of Hematology;2023-04-20

4. An Update on Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

5. Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcome;Leukemia & Lymphoma;2022-11-23